clinical trial · NCT04554940
A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
Achondroplasiavosoritide
brief summary
Study 111-209 is a Phase 2 randomized, open-label clinical trial of BMN 111 in infants and young children with a diagnosis of Achondroplasia at a heightened risk of requiring cervicomedullary decompression surgery
started
Oct 10, 2020
primary completion
Dec 1, 2027
completion
Dec 1, 2027
last updated
Mar 13, 2026
official title
A Randomized, Controlled, Open-label Clinical Trial With an Open-label Extension to Investigate the Safety of Vosoritide in Infants and Young Children With Achondroplasia at Risk of Requiring Cervicomedullary Decompression Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol